Response to “Refining FIB-4-based risk stratification in adverse drug reactions”
European Journal of Clinical Pharmacology · 2026-07 · 82 (7)
DOI: 10.1007/s00228-026-04101-y ↗Kurz gefasst
Leserbrief in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 17.06.2026. Verfasst von Joana Henze und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Pharmacology, University Hospital RWTH Aachen, Wendlingweg 2, D-52074, Aachen, Germany. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum RWTH Aachen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Institute of Clinical Pharmacology, University Hospital RWTH Aachen, Wendlingweg 2, D-52074, Aachen, Germany.
- Emergency Department, Klinikum Fürth, Fürth, Germany.
- Department of Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
- Central Emergency Department, Hospital Ingolstadt, Ingolstadt, Germany.
- Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.
- Department of Clinical Pharmacology, and Pharmacy and Biochemistry, University Tübingen, Tübingen, Germany.
Förderung
- Universitätsklinikum RWTH Aachen
Zitieren
APA
Henze, J., Goette, L., Dormann, H., Schneider, C. V., Meeßen, C., Knüppel-Ruppert, A., Kriegisch-Stumpf, A., Schwab, M., Stingl, J. C., & Just, K. S. (2026). Response to “Refining FIB-4-based risk stratification in adverse drug reactions”. European Journal of Clinical Pharmacology, 82(7). https://doi.org/10.1007/s00228-026-04101-y
Vancouver
Henze J, Goette L, Dormann H, Schneider CV, Meeßen C, Knüppel-Ruppert A, et al. Response to “Refining FIB-4-based risk stratification in adverse drug reactions”. European Journal of Clinical Pharmacology. 2026;82(7). doi:10.1007/s00228-026-04101-y
BibTeX
@article{Henze2026,
author = {Henze, Joana and Goette, Lennard and Dormann, Harald and Schneider, Carolin V and Meeßen, Corinna and Knüppel-Ruppert, Anja and Kriegisch-Stumpf, Andrea and Schwab, Matthias and Stingl, Julia C and Just, Katja S},
title = {Response to “Refining FIB-4-based risk stratification in adverse drug reactions”},
journal = {European Journal of Clinical Pharmacology},
year = {2026},
volume = {82},
number = {7},
doi = {10.1007/s00228-026-04101-y}
}
EUVIMED